Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion type Assertion NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_head.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion description "[These results suggest that efatutazone inhibits cell motility by antagonizing the TGF-?/Smad2 pathway and effectively prevents metastasis in NSCLC patients with acquired resistance to EGFR-TKI regardless of the resistance mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_provenance.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion evidence source_evidence_literature NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_provenance.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion SIO_000772 24698130 NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_provenance.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion wasDerivedFrom befree-20150227 NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_provenance.
- NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_assertion wasGeneratedBy ECO_0000203 NP370668.RANmpWj_TzXZUgPXGbMBtJCE8tHeYbAp3_p_lguQmH1Kk130_provenance.